Name | Company | P/L % | MPV |
|
---|---|---|---|---|
Lord Arbuthnot of Edrom | Neuro-bio / NMS:NBIX | 212.12% | £218,482.89 | |
Baroness Greenfield | Neuro-bio / NMS:NBIX | 192.56% | £204,795.15 | |
Lord Moynihan of Chelsea | Journey Medical / NCM:DERM | 24.33% | £87,032.09 | |
Lord Sassoon | Haleon / LSE:HLN.L | 13.24% | £79,268.07 | |
Baroness Deech | Zoetis / NYQ:ZTS | -2.72% | £68,092.80 | |
Lord Lloyd-Webber | Hikma Pharmaceuticals / LSE:HIK.L | -4.49% | £66,855.87 | |
Lord Moynihan of Chelsea | Evotec / NMS:EVO | -38.29% | £43,197.76 |